ArticleOncoimmunology2023
Eribulin mesylate exerts antitumor effects via CD103.
Kazumasa Oya et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleOncoimmunology2023
Kazumasa Oya et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.